Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation.

David ManninoMichael Bogart Guillaume GermainShirley P HuangAfisi S Ismaila François Laliberté Young Jung Sean D MacKnight Marjorie A Stiegler Mei Sheng Duh

Published in: International journal of chronic obstructive pulmonary disease (2022)

Prompt initiation of FF/UMEC/VI following a moderate or severe COPD exacerbation was associated with significant reductions in exacerbations and healthcare costs relative to delayed initiation.

Keyphrases

chronic obstructive pulmonary disease
healthcare
lung function
early onset
cystic fibrosis
health information
air pollution